§ 69.04.500. Drugs -- Misbranding by failure to give directions for use and warnings
A drug or device shall be deemed to be misbranded unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users: PROVIDED, That where any requirement of clause (1) of this section as applied to any drug or device, is not necessary for the protection of the public health, the director shall promulgate regulations exempting such drug or device from such requirements. Such regulations shall include the exemptions prescribed under section 502(f)(1) of the federal act, insofar as such exemptions are applicable hereunder.
[1945 c 257 § 68; Rem. Supp. 1945 § 6163-117. Prior: 1923 c 36 § 2; 1907 c 211 § 4.]
Sections: Previous 69.04.430 69.04.440 69.04.450 69.04.460 69.04.470 69.04.480 69.04.490 69.04.500 69.04.510 69.04.520 69.04.530 69.04.540 69.04.550 69.04.560 69.04.565 NextLast modified: April 7, 2009